C

Cellivery Therapeutics Inc
KOSDAQ:268600

Watchlist Manager
Cellivery Therapeutics Inc
KOSDAQ:268600
Watchlist
Price: 6 680 KRW -29.91%
Market Cap: 245B KRW
Have any thoughts about
Cellivery Therapeutics Inc?
Write Note

EV/S
Enterprise Value to Sales

10.8
Current
20.8
Median
3.9
Industry
Lower than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
10.8
=
Enterprise Value
264.6B KRW
/
Revenue
24.5B KRW
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
N/A
2-Years Forward
EV/S
N/A
3-Years Forward
EV/S
N/A

See Also

Discover More